VASCULAR ACCESS SITE PHLEBITIS

This adverse event was reported 4 times

VASCULAR ACCESS SITE PHLEBITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SUFENTANIL CITRATE 1 0.0008
1 SIPULEUCEL-T 2 0.0003
2 BLINATUMOMAB 1 0.0001
3 CEFAZOLIN SODIUM 1 0.0001
4 PROPOFOL 1 0.0000
5 ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE 2 0.0000
6 DIPHENHYDRAMINE HYDROCHLORIDE 2 0.0000
7 OMEPRAZOLE MAGNESIUM 2 0.0000
8 ACETAMINOPHEN 2 0.0000
See all drugs enriched for association with VASCULAR ACCESS SITE PHLEBITIS

VASCULAR ACCESS SITE PHLEBITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Autologous Cellular Immunotherapy [EPC] 2 0.0003
1 Gonadotropin Releasing Hormone Receptor Antagonist [EPC] 2 0.0001
2 General Anesthetic [EPC] 1 0.0000
3 Expectorant [EPC] 2 0.0000
See all drug classes enriched for association with VASCULAR ACCESS SITE PHLEBITIS